Acquisition by Uzonwanne Jude of 115770 shares of MyMD Pharmaceuticals subject to Rule 16b-3

MYMDDelisted Stock  USD 1.82  0.02  1.09%   
About 61% of MyMD Pharmaceuticals' investor base is looking to short. The analysis of current outlook of investing in MyMD Pharmaceuticals suggests that many traders are alarmed regarding MyMD Pharmaceuticals' prospects. The current market sentiment, together with MyMD Pharmaceuticals' historical and current headlines, can help investors time the market. In addition, many technical investors use MyMD Pharmaceuticals stock news signals to limit their universe of possible portfolio assets.
  
Filed transaction by Mymd Pharmaceuticals Inc director. Grant, award or other acquisition pursuant to Rule 16b-3

Read at macroaxis.com
MyMD insider trading alert for grant of stock option right to buy by Uzonwanne Jude, the corporate stakeholder, on 2nd of November 2023. This event was filed by Mymd Pharmaceuticals Inc with SEC on 2021-04-21. Statement of changes in beneficial ownership - SEC Form 4

MyMD Pharmaceuticals Fundamental Analysis

We analyze MyMD Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of MyMD Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of MyMD Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

EBITDA

EBITDA Comparative Analysis

MyMD Pharmaceuticals is currently under evaluation in ebitda category among its peers. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.

MyMD Pharmaceuticals Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with MyMD Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of MyMD Pharmaceuticals could also be used in its relative valuation, which is a method of valuing MyMD Pharmaceuticals by comparing valuation metrics with similar companies.

Peers

MyMD Pharmaceuticals Related Equities

UBXUnity Biotechnology   4.17   
0%
75.0%
RXRXRecursion Pharmaceuticals   3.58   
0%
64.0%
GOVXGeoVax Labs   2.26   
0%
40.0%
DSGNDesign Therapeutics   2.25   
0%
40.0%
BOLTBolt Biotherapeutics   2.00   
0%
35.0%
NVCTNuvectis Pharma   1.53   
0%
27.0%
XBIOXenetic Biosciences   1.47   
0%
26.0%
REPLReplimune   1.30   
0%
23.0%
KZRKezar Life   0.94   
0%
16.0%
SRZNSurrozen   0.08   
0%
1.0%
AVIRAtea Pharmaceuticals   0.31   
5.0%
0%
LGNDLigand Pharmaceuticals   0.37   
6.0%
0%
KRONKronos Bio   1.04   
18.0%
0%
LRMRLarimar Therapeutics   1.25   
22.0%
0%
PASGPassage Bio   1.52   
27.0%
0%
LYELLyell Immunopharma   1.61   
28.0%
0%
ORICOric Pharmaceuticals   1.68   
30.0%
0%
NBYNovaBay Pharmaceuticals   1.89   
33.0%
0%
GOSSGossamer Bio   2.33   
41.0%
0%
KROSKeros Therapeutics   2.39   
42.0%
0%
REVBRevelation Biosciences   3.23   
58.0%
0%
LYRALyra Therapeutics   5.56   
100.0%
0%
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.

Other Consideration for investing in MyMD Stock

If you are still planning to invest in MyMD Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the MyMD Pharmaceuticals' history and understand the potential risks before investing.
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Transaction History
View history of all your transactions and understand their impact on performance
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance